Muscle-specific interleukin-6 deletion influences body weight and body fat in a sex-dependent manner

Brain, Behavior, and Immunity

Volumn 40, Issue , 2014, Pages 121-130

  Ferrer, Beatriz ^a   Navia, Belén ^b   Giralt, Mercedes ^a   Comes, Gemma ^a   Carrasco, Javier ^a   Molinero, Amalia ^a   Quintana, Albert ^a,c   Señarís, Rosa M ^b   Hidalgo, Juan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Body weight; High fat diet; Hypothalamic factors; IL 6; Insulin

Indexed keywords

CYTOKINE; INSULIN; LEPTIN; MUSCLE SPECIFIC INTERLEUKIN 6; NEUROPEPTIDE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; INTERLEUKIN 6;

ADIPOCYTE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY FAT; BODY TEMPERATURE; BODY WEIGHT; COLD EXPOSURE; CONTROLLED STUDY; ENERGY EXPENDITURE; FATTY LIVER; FEMALE; FOOD INTAKE; GENE DELETION; HISTOLOGY; HYPOTHALAMUS; LIPID DIET; MALE; MEASUREMENT; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; SEX DIFFERENCE; WEIGHT GAIN; ADIPOSE TISSUE; ANIMAL; ENERGY METABOLISM; GENETICS; GLUCOSE BLOOD LEVEL; KNOCKOUT MOUSE; METABOLISM; SKELETAL MUSCLE; THERMOREGULATION;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; BODY TEMPERATURE REGULATION; BODY WEIGHT; ENERGY METABOLISM; FEMALE; HYPOTHALAMUS; INSULIN; INTERLEUKIN-6; LEPTIN; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NEUROPEPTIDES; OBESITY; SEX FACTORS;

EID: 84904098523     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.03.001     Document Type: Article

References (51)

1. Abramoff M.D., Magelhaes P.J., Ram S.J. Image processing with ImageJ. Biophotonics Int. 2004, 11:36-42.
2. Allen T.L., Febbraio M.A. IL6 as a mediator of insulin resistance: fat or fiction?. Diabetologia 2010, 53:399-402.
3. Archer J. Tests for emotionality in rats and mice: a review. Anim. Behav. 1973, 21:205-235.
4. Badman M.K., Flier J.S. The gut and energy balance: visceral allies in the obesity wars. Science 2005, 307:1909-1914.
5. Barros R.P., Machado U.F., Gustafsson J.A. Estrogen receptors: new players in diabetes mellitus. Trends Mol. Med. 2006, 12:425-431.
6. Bastard J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 2000, 85:3338-3342.
7. Benrick A., Schéle E., Pinnock S.B., Wernstedt-Asterholm I., Dickson S.L., Karlsson-Lindahl L., Jansson J.O. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei. J. Neuroendocrinol. 2009, 21:620-628.
8. Boissier J.R., Simon P. La reaction d'exploration chez la souris. Therapie 1962, 17:1225-1232.
9. Bothe G.W., Haspel J.A., Smith C.L., Wiener H.H., Burden S.J. Selective expression of Cre recombinase in skeletal muscle fibers. Genesis 2000, 26:165-166.
10. Carey A.L., Febbraio M.A. Interleukin-6 and insulin sensitivity: friend or foe?. Diabetologia 2004, 47:1135-1142.
11. Charmandari E., Tsigos C., Chrousos G. Endocrinology of the stress response. Annu. Rev. Physiol. 2005, 67:259-284.
12. Ellingsgaard H., Hauselmann I., Schuler B., Habib A.M., Baggio L.L., Meier D.T., Eppler E., Bouzakri K., Wueest S., Muller Y.D., et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat. Med. 2011, 17:1481-1489.
13. Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 2012, 8:1254-1266.
14. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
15. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 1994, 180:1243-1250.
16. Febbraio M.A., Steensberg A., Keller C., Starkie R.L., Nielsen H.B., Krustrup P., Ott P., Secher N.H., Pedersen B.K. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J. Physiol. 2003, 549:607-612.
17. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacology 1975, 44:53-59.
18. Gao Q., Mezei G., Nie Y., Rao Y., Choi C.S., Bechmann I., Leranth C., Toran-Allerand D., Priest C.A., Roberts J.L., et al. Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat. Med. 2007, 13:89-94.
19. Hidalgo J., Florit S., Giralt M., Ferrer B., Keller C., Pilegaard H. Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav. Immun. 2010, 24:119-261.
20. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K.H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA 1985, 82:5490-5494.
21. Kasuga M. Insulin resistance and pancreatic beta cell failure. J. Clin. Invest. 2006, 116:1756-1760.
22. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86:1243-1254.
23. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005, 54:S114-S124.
24. Lemonnier D. Effect of age, sex, and sites on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet. J. Clin. Invest. 1972, 51:2907-2915.
25. Li G., Klein R.L., Matheny M., King M.A., Meyer E.M., Scarpace P.J. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 2002, 115:879-889.
26. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997, 82:4196-4200.
27. Mooney R.A. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 2007, 102:816-818.
28. Ogawa W., Kasuga M. Cell signaling. Fat stress and liver resistance. Science 2008, 322:1483-1484.
29. Pan W., Kastin A.J. Adipokines and the blood-brain barrier. Peptides 2007, 28:1317-1330.
30. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, Sydney.
31. Pazos P., Lima L., Casanueva F.F., Diéguez C., García M.C. Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PLoS One 2013, 8(8):e72339.
32. Pedersen B.K., Febbraio M.A. Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. J. Appl. Physiol. 2007, 102:814-816.
33. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012, 8:457-465.
34. Plomgaard P., Bouzakri K., Krogh-Madsen R., Mittendorfer B., Zierath J.R., Pedersen B.K. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005, 54:2939-2945.
35. Plomgaard P., Nielsen A.R., Fischer C.P., Mortensen O.H., Broholm C., Penkowa M., Krogh-Madsen R., Erikstrup C., Lindegaard B., Petersen A.M., et al. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 2007, 50:2562-2571.
36. Quintana A., Erta M., Ferrer B., Comes G., Giralt M., Hidalgo J. Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav. Immun. 2013, 27:162-173.
37. Schéle E., Fekete C., Egri P., Füzesi T., Palkovits M., Keller E., Liposits Z., Gereben B., Karlsson-Lindahl L., Shao R., et al. Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus. J. Neuroendocrinol. 2012, 24:930-943.
38. Schéle E., Benrick A., Grahnemo L., Egecioglu E., Anesten F., Pálsdóttir V., Jansson J.O. Interrelation between interleukin-1 (IL-1), IL-6 and body fat regulating circuits of the hypothalamic arcuate nucleus. J. Neuroendocrinol. 2013, 25:580-589.
39. Señarís R.M., Trujillo M.L., Navia B., Comes G., Ferrer B., Giralt M., Hidalgo J. Interleukin-6 regulates the expression of hypothalamic neuropeptides involved in body weight in a gender-dependent way. J. Neuroendocrinol. 2011, 23:675-686.
40. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardí M., Muñoz-Cánoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008, 7:33-44.
41. Shirazi R., Palsdottir V., Collander J., Anesten F., Vogel H., Langlet F., Jaschke A., Schürmann A., Prévot V., Shao R., et al. Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6. Proc. Natl. Acad. Sci. USA 2013, 110:16199-16204.
42. Steensberg A., van Hall G., Osada T., Sacchetti M., Saltin B., Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 2000, 529:237-242.
43. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol. Cell Biol. 1995, 15:4971-4979.
44. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 2001, 9:414-417.
45. Wallenius K., Wallenius V., Sunter D., Dickson S.L., Jansson J.O. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem. Biophys. Res. Commun. 2002, 293:560-565.
46. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., Ohlsson C., Jansson J.O. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 2002, 8:75-79.
47. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 2005, 115:1111-1119.
48. Wernstedt I., Edgley A., Berndtsson A., Faldt J., Bergstrom G., Wallenius V., Jansson J.O. Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291:R551-R557.
49. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 1998, 101:311-320.
50. Yakar S., Nunez N.P., Pennisi P., Brodt P., Sun H., Fallavollita L., Zhao H., Scavo L., Novosyadlyy R., Kurshan N., et al. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 2006, 147:5826-5834.
51. Young L.J., Muns S., Wang Z., Insel T.R. Changes in oxytocin receptor mRNA in rat brain during pregnancy and the effects of estrogen and interleukin-6. J. Neuroendocrinol. 1997, 9:859-865.